Vés al contingut

“Som la primera biotecnològica espanyola en utilitzar el micromecenatge per accions”, Giralt/Tarragó

Innovació
30 gen. 15

Images

Participants

Imatge
Emeritus Professor
Tel.+34 93 40 37125
Imatge
Alumni - Research Associate
Tel.+34 93 40 37127

Contact

Imatge
Communication Officer
Tel.+34 93 40 37255

SmartQuimic entrevista els científics de l’IRB Barcelona i cofundadors de l’spin off Iproteos, Teresa Tarragó i Ernest Giralt, guardonats amb el premi EXPOQUIMIA ’14 per la creació de l’IPR19, un nou fàrmac pel tractament de dèficits cognitius associats a l’esquizofrènia.

Llegir l’entrevista a SmartQuimic (en castellà)

 

About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 28 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).